They applied first to the FDA, stating that while the drugs to be involved in the lethal injection had been approved, the manner in which they were going to be used had not, in violation of the Food, Drug, and Cosmetic Act's prohibition against "misbranding".
More simply, they were arguing that the FDA had not certified that the drugs were "safe and effective" for human executions, and thus should be barred for being distributed via interstate commerce.